Changes in the Concentrations of Proangiogenic Cytokines in Human Brain Glioma and Acute Lymphoblastic Leukemia

• Published in: International journal of molecular sciences Vol. 25; no. 5; p. 2586
• Main Authors: Oldak, Lukasz, Zielinska, Zuzanna, Milewska, Patrycja, Chludzinska-Kasperuk, Sylwia, Latoch, Eryk, Konończuk, Katarzyna, Krawczuk-Rybak, Maryna, Starosz, Aleksandra, Grubczak, Kamil, Reszeć, Joanna, Gorodkiewicz, Ewa
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 23-02-2024; MDPI
• Subjects: Acute lymphocytic leukemia; Adult; Angiogenesis; Antimitotic agents; Antineoplastic agents; Apoptosis; biomarkers; Blood diseases; Blood vessels; Bone marrow; Brain; Brain - metabolism; Brain tumors; Cancer; Cancer therapies; Chemotherapy; Child; childhood acute lymphoblastic leukemia; Chronic obstructive pulmonary disease; Classification; Cytokines; Cytokines - metabolism; Development and progression; Exercise; FGF-2; Fibroblast Growth Factor 2 - metabolism; Fibroblast growth factors; Fibroblasts; Glioma; Glioma - metabolism; Gliomas; Hematology; Heparan sulfate; Humans; Hypoxia; Kinases; Leukemia; Lymphoma; Male; Medical prognosis; Nervous system; Oncology, Experimental; Pathogenesis; Patients; Perceptions; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumors; Vascular endothelial growth factor; Vascular Endothelial Growth Factor A - metabolism; Vascular Endothelial Growth Factors - metabolism; VEGF-A; VEGF-R2; Poland; Taiwan; VEGF-R2; FGF-2; glioma; childhood acute lymphoblastic leukemia; VEGF-A; biomarkers
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25052586

Acute lymphoblastic leukemia (ALL) and glioma are some of the most common malignancies, with ALL most often affecting children and glioma affecting adult men. Proangiogenic cytokines and growth factors play an important role in the development of both of these tumors. Glioma is characterized by an extremely extensive network of blood vessels, which continues to expand mainly in the process of neoangiogenesis, the direct inducers of which are cytokines from the family of vascular endothelial growth factors, i.e., vascular endothelial growth factor (VEGF-A) and its receptor vascular endothelial growth factor receptor 2 (VEGF-R2), as well as a cytokine from the fibroblast growth factor family, fibroblast growth factor 2 (FGF-2 or bFGF). Growth factors are known primarily for their involvement in the progression and development of solid tumors, but there is evidence that local bone marrow angiogenesis and increased blood vessel density are also present in hematological malignancies, including leukemias. The aim of this study was to examine changes in the concentrations of VEGF-A, VEGF-R2, and FGF-2 (with a molecular weight of 17 kDa) in a group of patients divided into specific grades of malignancy (glioma) and a control group; changes of VEGF-A and FGF-2 concentrations in childhood acute lymphoblastic leukemia and a control group; and to determine correlations between the individual proteins as well as the influence of the patient's age, diet, and other conditions that may place the patient in the risk group. During the statistical analysis, significant differences in concentrations were found between the patient and control groups in samples from people with diagnosed glioma and from children with acute lymphoblastic leukemia, but in general, there are no significant differences in the concentrations of VEGF-A, VEGF-R2, and FGF-2 between different grades of glioma malignancy. Among individuals treated for glioma, there was no significant impact from the patient's gender and age, consumption of food from plastic packaging, frequency of eating vegetables and fruit, smoking of tobacco products, the intensity of physical exercise, or the general condition of the body (Karnofsky score) on the concentrations of the determined cytokines and receptor. The listed factors do not bring about an actual increase in the risk of developing brain glioma.